Current Opinion in Nephrology & Hypertension,
Journal Year:
2019,
Volume and Issue:
28(4), P. 397 - 405
Published: March 29, 2019
Acute
kidney
injury
(AKI)
remains
a
major
unmet
medical
need
and
associates
with
high
morbidity,
mortality,
healthcare
costs.
Among
survivors,
long-term
outcomes
of
AKI
can
include
development
chronic
disease
(CKD)
or
progression
preexisting
CKD.
In
this
review,
we
focus
on
ongoing
efforts
by
the
community
to
understand
human
CKD
continuum,
an
emphasis
cellular
stress
responses
that
underlie
maladaptive
persist
in
acute-to-chronic
phase.
The
is
work
has
been
published
past
year
rapidly
expanding
field.Recent
studies
preclinical
models
highlight
importance
mitochondrial
dysfunction,
cell
death,
inflammation
underlying
pathogenesis
AKI.
These
pathogenic
mechanisms
resolve
adaptive
repair
but
leads
progressive
disease.
complexity
interconnections
these
pathways
involve
cross-talk
between
tubular
epithelium,
endothelium,
interstitial
compartments.Approaches
which
lessen
counteract
represent
novel
strategies
prevent
stop
slow
down
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1755 - 1755
Published: Feb. 1, 2024
This
article
provides
a
thorough
overview
of
the
biomarkers,
pathophysiology,
and
molecular
pathways
involved
in
transition
from
acute
kidney
injury
(AKI)
disease
(AKD)
to
chronic
(CKD).
It
categorizes
biomarkers
AKI
into
stress,
damage,
functional
markers,
highlighting
their
importance
early
detection,
prognosis,
clinical
applications.
review
also
highlights
links
between
renal
pathophysiological
mechanisms
underlying
AKD,
including
hypoperfusion,
sepsis,
nephrotoxicity,
immune
responses.
In
addition,
various
molecules
play
pivotal
roles
inflammation
hypoxia,
triggering
maladaptive
repair,
mitochondrial
dysfunction,
system
reactions,
cellular
senescence
cells.
Key
signaling
pathways,
such
as
Wnt/β-catenin,
TGF-β/SMAD,
Hippo/YAP/TAZ,
promote
fibrosis
impact
function.
The
renin-angiotensin-aldosterone
(RAAS)
triggers
cascade
leading
fibrosis,
with
aldosterone
exacerbating
oxidative
stress
changes
that
fibrosis.
evidence
suggests
RAS
inhibitors
may
protect
against
CKD
progression,
especially
post-AKI,
though
more
extensive
trials
are
needed
confirm
full
impact.
Current Opinion in Nephrology & Hypertension,
Journal Year:
2020,
Volume and Issue:
29(3), P. 310 - 318
Published: March 24, 2020
Purpose
of
review
Despite
improvements
in
acute
kidney
injury
(AKI)
detection,
therapeutic
options
to
halt
the
progression
AKI
chronic
disease
(CKD)
remain
limited.
In
this
review,
we
focus
on
recent
discoveries
related
pathophysiology
CKD
continuum,
particularly
involving
renal
tubular
epithelial
cells,
and
also
discuss
ongoing
clinical
trials.
While
our
is
injured
cells
as
initiators
cascade
events
resulting
paracrine
effects
other
kidney,
summation
maladaptive
responses
from
various
cell
types
ultimately
leads
fibrosis
dysfunction
characteristic
CKD.
Recent
findings
that
will
include,
but
are
not
limited
to,
characterizations
of:
association
between
cycle
arrest
cellular
senescence
its
contribution
fibrosis,
inflammation
with
persistent
cytokine
production
lymphocyte
infiltration
among
unrepaired
tubules,
mitochondrial
a
unique
role
cytosolic
mitochondria
DNA
fibrogenesis,
prolyl
hydroxylase
domain
proteins
potential
targets,
novel
mechanisms
Hippo/yes-associated
protein/transcriptional
coactivator
PDZ-binding
pathway.
Summary
Potential
address
be
informed
by
better
understanding
fibrogenic
pathways.
advances
suggest
additional
drug
targets
pathways
leading
fibrosis.
Journal of Clinical Investigation,
Journal Year:
2019,
Volume and Issue:
129(11), P. 4797 - 4816
Published: Oct. 6, 2019
Maladaptive
proximal
tubule
(PT)
repair
has
been
implicated
in
kidney
fibrosis
through
induction
of
cell-cycle
arrest
at
G2/M.
We
explored
the
relative
importance
PT
DNA
damage
response
(DDR)
by
genetically
inactivating
ataxia
telangiectasia
and
Rad3-related
(ATR),
which
is
a
sensor
upstream
initiator
DDR.
In
human
chronic
disease,
ATR
expression
inversely
correlates
with
damage.
was
upregulated
approximately
70%
Lotus
tetragonolobus
lectin-positive
(LTL+)
cells
cisplatin-exposed
organoids.
Inhibition
resulted
greater
cell
injury
organoids
cultured
cells.
PT-specific
Atr-knockout
(ATRRPTC-/-)
mice
exhibited
function
impairment,
damage,
than
did
WT
to
induced
either
cisplatin,
bilateral
ischemia-reperfusion,
or
unilateral
ureteral
obstruction.
ATRRPTC-/-
had
more
G2/M
phase
after
similar
treatments.
conclusion,
activation
key
component
DDR,
confers
protective
effect
mitigating
maladaptive
consequent
that
follow
injury.
Journal of the American Society of Nephrology,
Journal Year:
2019,
Volume and Issue:
31(1), P. 23 - 38
Published: Sept. 19, 2019
Significance
Statement
Having
a
comprehensive
transcriptional
profile
of
the
proximal
tubule
in
health
and
fibrosis
would
likely
enhance
understanding
perhaps
help
explain
why
CKD
progresses
more
quickly
males
versus
females.
To
obtain
complete
picture
gene
expression
tubule,
authors
performed
deep
translational
profiling
this
segment
mouse
model
kidney
fibrosis.
Their
findings
demonstrate
substantial
sex
differences
transcripts
expressed
cells
females,
indicate
that
drives
through
inflammatory
profibrotic
paracrine
signaling.
The
study
also
identified
439
long
noncoding
RNAs
143
which
undergo
differential
regulation
fibrosis,
suggesting
type
RNA
has
unanticipated
regulatory
roles
Background
Proximal
injury
can
initiate
CKD,
with
progression
rates
are
approximately
50%
faster
precise
changes
nephron
during
potential
between
sexes
remain
undefined.
Methods
We
generated
mice
tubule–specific
an
L10a
ribosomal
subunit
protein
fused
enhanced
green
fluorescent
protein.
unilateral
ureteral
obstruction
surgery
on
four
male
three
female
to
induce
inflammation
collected
bulk
cortex
mRNA
at
day
5
or
10,
sequenced
samples
depth
30
million
reads.
applied
computational
methods
identify
sex-biased
shared
molecular
responses
fibrotic
injury,
including
up-
downregulated
(lncRNAs)
regulators,
used
situ
hybridization
validate
critical
genes
pathways.
Results
>17,000
each
group,
145
G-protein–coupled
receptors.
More
than
700
were
differentially
>4000
displaying
altered
enriched
for
proinflammatory
Our
identification
nearly
150
lncRNAs
suggests
they
may
have
roles.
Network
analysis
prioritized
transcription
factors
such
as
Irf1
,
Nfkb1
Stat3
drivers
progression.
Conclusions
This
transcriptomic
map
revealed
sexually
dimorphic
reflect
sex-related
disparities
modules,
previously
unappreciated
bidirectional
lncRNA
regulation.
Journal of the American Society of Nephrology,
Journal Year:
2021,
Volume and Issue:
32(10), P. 2467 - 2483
Published: June 14, 2021
Significance
Statement
AKI
is
a
frequent
clinical
problem
without
definitive
therapies.
We
developed
an
efficient
RNAi
therapy
against
by
engineering
red
blood
cell-derived
extracellular
vesicles
(REVs)
with
targeting
peptides
and
therapeutic
siRNAs.
REVs
targeted
Kim-1–binding
peptide
LTH
efficiently
delivered
P65
Snai1
siRNAs
to
the
injured
tubules,
leading
reduced
expression
of
P-p65
Snai1.
Dual
suppression
inhibited
renal
inflammation
fibrosis
in
mice
subjected
ischemia/reperfusion
injury
unilateral
ureteral
obstruction,
blunted
chronic
progression
ischemic
AKI.
This
study
provides
platform,
REV
LTH,
for
delivery
therapeutics
into
tubular
cells,
suggests
viability
as
avenue
Background
significant
public
health
high
morbidity
mortality.
Unfortunately,
no
treatment
available
RNA
interference
(RNAi)
new
potent
method
gene
tackle
this
issue.
Methods
engineered
cell–derived
treat
experimental
mouse
model
after
(I/R)
obstruction
(UUO).
Phage
display
identified
that
bind
kidney
molecule-1
(Kim-1).
RNA-sequencing
(RNA-seq)
characterized
transcriptome
explore
potential
targets.
Results
(REV
)
homed
accumulated
at
tubules
I/R
injury.
transcription
factors
drive
Taking
advantage
established
,
were
consequently
blocked
tubules.
Moreover,
dual
significantly
improved
I/R-
UUO-induced
alleviating
tubulointerstitial
fibrosis,
potently
abrogated
transition
CKD.
Conclusions
A
vesicle
platform
Kim-1
acutely
Aging and Disease,
Journal Year:
2022,
Volume and Issue:
13(3), P. 712 - 712
Published: Jan. 1, 2022
Renal
fibrosis
is
a
common
process
of
almost
all
the
chronic
kidney
diseases
progressing
to
end-stage
disease.
As
highly
conserved
lysosomal
protein
degradation
pathway,
autophagy
responsible
for
degrading
aggregates,
damaged
organelles,
or
invading
pathogens
maintain
intracellular
homeostasis.
Growing
evidence
reveals
that
involved
in
progression
renal
fibrosis,
both
tubulointerstitial
compartment
and
glomeruli.
Nevertheless,
specific
role
has
still
not
been
fully
understood.
Therefore,
this
review
we
will
describe
characteristics
summarize
recent
advances
understanding
functions
fibrosis.
Moreover,
problem
existing
field
possibility
as
potential
therapeutic
target
have
also
discussed.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 4, 2022
Abstract
Acute
kidney
injury
(AKI)
is
frequent,
often
fatal
and,
for
lack
of
specific
therapies,
can
leave
survivors
with
chronic
disease
(CKD).
We
characterize
the
distribution
tubular
cells
(TC)
undergoing
polyploidy
along
AKI
by
DNA
content
analysis
and
single
cell
RNA-sequencing.
Furthermore,
we
study
functional
roles
polyploidization
using
transgenic
models
drug
interventions.
identify
YAP1-driven
TC
outside
site
as
a
rapid
way
to
sustain
residual
function
early
during
AKI.
This
survival
mechanism
comes
at
cost
senescence
polyploid
promoting
interstitial
fibrosis
CKD
in
survivors.
However,
targeting
after
phase
prevent
AKI-CKD
transition
without
influencing
lethality.
Senolytic
treatment
prevents
blocking
repeated
cycles.
These
results
revise
current
pathophysiological
concept
how
responds
acute
novel
druggable
target
improve
prognosis
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(18), P. 14019 - 14019
Published: Sept. 13, 2023
Acute
kidney
injury
(AKI)
is
one
of
the
main
conditions
responsible
for
chronic
disease
(CKD),
including
end-stage
renal
(ESRD)
as
a
long-term
complication.
Besides
short-term
complications,
such
electrolyte
and
acid-base
disorders,
fluid
overload,
bleeding
complications
or
immune
dysfunctions,
AKI
can
develop
injuries
subsequent
CKD
through
fibrosis
pathways.
Kidney
pathological
process
defined
by
excessive
extracellular
matrix
(ECM)
deposition,
evidenced
in
with
maladaptive
architecture
restoration.
So
far,
cited
processes
to
transition
were
epithelial,
endothelial,
pericyte,
macrophage
fibroblast
myofibroblasts.
These
are
smooth
muscle
actin
(SMA)
synthesis
abnormal
architecture.
Recently,
progress
ESRD
gained
lot
interest,
impressive
progression
discovering
mechanisms
involved
fibrosis,
cellular
molecular
Risk
factors
mentioned
frequency
severity
injury,
diseases
uncontrolled
hypertension,
diabetes
mellitus,
obesity
unmodifiable
risk
(i.e.,
genetics,
older
age
gender).
To
provide
better
understanding
CKD,
we
have
selected
relevant
updated
information
regarding
AKIs
unfavorable
evolution
incriminated
state,
along
possible
therapeutic
approaches
preventing
delaying
from
AKI.
Kidney International,
Journal Year:
2024,
Volume and Issue:
105(4), P. 709 - 716
Published: Jan. 9, 2024
Tubular
epithelial
cells
(TC)
compose
the
majority
of
kidney
parenchyma
and
play
fundamental
roles
in
maintaining
homeostasis.
Like
other
tissues,
mostly
immature
TC
with
progenitor
capabilities
are
able
to
replace
lost
during
injury
via
clonal
expansion
differentiation.
In
contrast,
differentiated
lack
this
capacity.
However,
as
is
frequently
exposed
toxic
injuries,
evolution
positively
selected
a
response
program
that
endows
maintain
residual
function
injury.
Recently,
we
others
have
described
polyploidization
TC,
mechanism
augment
remnant
after
an
by
rapid
hypertrophy.
Polyploidy
condition
characterized
more
than
two
complete
sets
chromosomes.
Polyploid
often
display
increased
functional
capacity
generally
resilient
stress
evidenced
being
conserved
across
many
plants
eukaryote
species
from
flies
mammals.
Here,
discuss
occurrence
polyploidy
different
contexts
conditions
how
integrates
into
existing
concepts
cell
responses
Collectively,
aim
at
stimulating
acquisition
novel
knowledge
field
well
accelerating
translation
basic
clinical
sphere.